HOLX
HOLOGIC INC
No data for this timeframe.
Vol
Inst. Holders50 funds
Inst. Value$9.2B
Inst. Activity31 buys / 19 sells
SEC Reports5
Congressional2 trades
Exchange Nasdaq·Sector X-Ray Apparatus & Tubes & Related Irradiation Apparatus·Inc. DE·CIK 0000859737
Recent Activity
Apr 30, 2026
earnings_calendar
HOLX Q2 2026 Earnings After Market Close — 2026-04-30
Apr 17, 2026
SEC
Hologic, Inc. has filed Form 15-12G to terminate its SEC registration and suspend reporting obligations, effective April
15-12G — Impact 7/10
Apr 13, 2026
SEC
Hologic Inc. has two shelf registration statements (File Nos. 333-73596 and 033-65019) that became effective on April 10
EFFECT — Impact 3/10
Apr 7, 2026
SEC
Hologic completed its acquisition by Blackstone and TPG, becoming a private company. The deal closed at $76 per share in
8-K — Impact 9/10
Apr 7, 2026
Insider
COHN BENJAMIN JORDAN disposed of 17,964 shares
Principal Accounting Officer
Apr 7, 2026
Insider
COHN BENJAMIN JORDAN disposed of 10,861 shares
Principal Accounting Officer
Apr 7, 2026
Insider
COHN BENJAMIN JORDAN was granted 5,665 shares
Principal Accounting Officer
Inst.
FIL Ltd — ADD
7,821,581 shares ($591.2M)
Price Targets
Historical data — last covering-analyst action Jan 2026. No current recommendation available.
$76.67 (Jan 2026)
Current $76.01
Low $76.00
Median $76.00
High $78.00
9 analysts
$76.00
$78.00
Analyst Ratings
0Strong Buy
0Buy
20Hold
1Sell
2Strong Sell
Historical Analyst Actions
| Date | Firm | Action | Rating |
|---|---|---|---|
| Jan 12, 2026 | Argus Research | DOWNGRADE | Buy → Hold |
| Jan 5, 2026 | Evercore ISI Group | DOWNGRADE | Outperform → In-Line |
| Nov 11, 2025 | Morgan Stanley | MAINTAIN | Equal-Weight → Equal-Weight |
| Oct 23, 2025 | Mizuho | DOWNGRADE | Outperform → Neutral |
| Oct 22, 2025 | Raymond James | DOWNGRADE | Outperform → Market Perform |
Earnings Estimates
| Period | EPS Est. | Range | Growth | # |
|---|---|---|---|---|
| Next FY | $3.78 | $3.05 — $4.39 | 15% YoY | 7 |
| Current FY | $4.46 ▲ +0.8% | $4.35 — $4.64 | 5% YoY | 15 |
| Current Q | $1.07 ▲ +1.4% | $1.01 — $1.14 | 4% YoY | 12 |
| Next Q | $1.12 ▲ +1.3% | $1.09 — $1.18 | 4% YoY | 10 |
Latest Reports
NEUTRAL
15-12G
7/10
Hologic, Inc. has filed Form 15-12G to terminate its SEC registration and suspend reporting obligations, effective April
Apr 17, 2026
NEUTRAL
EFFECT
3/10
Hologic Inc. has two shelf registration statements (File Nos. 333-73596 and 033-65019) that became effective on April 10
Apr 13, 2026
Top Institutional Holders
| Fund | Value | Move |
|---|---|---|
| BlackRock, Inc. | $1.7B | — |
| VANGUARD CAPITAL MANAGEMENT LLC | $1.1B | — |
| STATE STREET CORP | $755.2M | — |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $727.2M | — |
| FIL Ltd | $591.2M | ADD |
Recent Insider Trades
| Date | Insider | Type | Value |
|---|---|---|---|
| Apr 7, 2026 | COHN BENJAMIN | D | $0.00 |
| Apr 7, 2026 | COHN BENJAMIN | D | $0.00 |
| Apr 7, 2026 | COHN BENJAMIN | A | $0.00 |
| Apr 7, 2026 | COHN BENJAMIN | D | $0.00 |
| Apr 7, 2026 | Dockendorff Charles | D | $0.00 |
Congressional Trades
1 members: 0 buys, 1 sells
| Member | Party | Type | Amount |
|---|---|---|---|
| Laura Friedman | D | EXCHANGE | $1,001 - $15,000 |
| Laura Friedman | D | SELL | $1,001 - $15,000 |
50 institutional holders with $9.2B total value (121,976,337 shares) as of 2026-Q1. Top holders: BlackRock,, VANGUARD, STATE. Net buying activity: 31 institutions added/increased vs 19 reduced.
Top Institutional Holders — 2026-Q1
| # | Fund | Shares | Value | % of Tracked | Last Move |
|---|---|---|---|---|---|
| 1 | BlackRock, Inc. | 22,520,444 | $1.7B | 18.5% | — |
| 2 | VANGUARD CAPITAL MANAGEMENT LLC | 14,503,914 | $1.1B | 11.9% | — |
| 3 | STATE STREET CORP | 9,990,906 | $755.2M | 8.2% | — |
| 4 | VANGUARD PORTFOLIO MANAGEMENT LLC | 9,620,600 | $727.2M | 7.9% | — |
| 5 | FIL Ltd | 7,821,581 | $591.2M | 6.4% | ADD +49.6% |
| 6 | BALYASNY ASSET MANAGEMENT L.P. | 4,722,968 | $357.0M | 3.9% | DOUBLED +193.7% |
| 7 | Pentwater Capital Management LP | 4,500,224 | $340.2M | 3.7% | — |
| 8 | MORGAN STANLEY | 3,573,011 | $270.1M | 2.9% | ADD +51.3% |
| 9 | Invesco Ltd. | 3,164,586 | $239.2M | 2.6% | — |
| 10 | ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 2,921,130 | $220.8M | 2.4% | — |
| 11 | GOLDMAN SACHS GROUP INC | 2,322,673 | $175.6M | 1.9% | — |
| 12 | BANK OF AMERICA CORP /DE/ | 2,254,024 | $170.4M | 1.8% | — |
| 13 | TUDOR INVESTMENT CORP ET AL | 2,196,804 | $166.1M | 1.8% | ADD +36.5% |
| 14 | DEUTSCHE BANK AG\ | 2,173,847 | $164.3M | 1.8% | ADD +34.1% |
| 15 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 2,157,358 | $163.1M | 1.8% | — |
| 16 | EARNEST PARTNERS LLC | 1,842,926 | $139.3M | 1.5% | — |
| 17 | Amundi | 1,469,196 | $111.1M | 1.2% | — |
| 18 | Legal & General Group Plc | 1,413,564 | $106.9M | 1.2% | — |
| 19 | Neuberger Berman Group LLC | 1,361,861 | $102.9M | 1.1% | ADD +44.6% |
| 20 | VANGUARD FIDUCIARY TRUST CO | 1,252,673 | $94.7M | 1.0% | — |
Recent Position Changes
| Fund | Action | Prev Shares | Curr Shares | Change % | Value | Quarter |
|---|---|---|---|---|---|---|
| FIL Ltd | ADD | 5,227,433 | 7,821,581 | +49.6% | $591.2M | 2026-Q1 |
| BALYASNY ASSET MANAGEMENT L.P. | DOUBLED | 1,608,340 | 4,722,968 | +193.7% | $357.0M | 2026-Q1 |
| MORGAN STANLEY | ADD | 2,362,076 | 3,573,011 | +51.3% | $270.1M | 2026-Q1 |
| TUDOR INVESTMENT CORP ET AL | ADD | 1,609,400 | 2,196,804 | +36.5% | $166.1M | 2026-Q1 |
| DEUTSCHE BANK AG\ | ADD | 1,620,529 | 2,173,847 | +34.1% | $164.3M | 2026-Q1 |
| Neuberger Berman Group LLC | ADD | 941,497 | 1,361,861 | +44.6% | $102.9M | 2026-Q1 |
| NATIONAL BANK OF CANADA /FI/ | DOUBLED | 144,810 | 864,725 | +497.1% | $65.4M | 2026-Q1 |
| MACKENZIE FINANCIAL CORP | TRIM | 1,016,337 | 676,423 | -33.4% | $51.1M | 2026-Q1 |
| PICTON MAHONEY ASSET MANAGEMENT | ADD | 501,214 | 650,514 | +29.8% | $49.2M | 2026-Q1 |
| Nuveen, LLC | ADD | 496,852 | 631,881 | +27.2% | $47.8M | 2026-Q1 |
| ING GROEP NV | DOUBLED | 28,764 | 627,305 | +2080.9% | $47.4M | 2026-Q1 |
| FMR LLC | ADD | 472,087 | 604,606 | +28.1% | $45.7M | 2026-Q1 |
| LMR Partners LLP | ADD | 439,947 | 598,714 | +36.1% | $45.3M | 2026-Q1 |
| Verition Fund Management LLC | DOUBLED | 278,228 | 578,395 | +107.9% | $43.7M | 2026-Q1 |
| TORONTO DOMINION BANK | DOUBLED | 85,638 | 567,153 | +562.3% | $42.9M | 2026-Q1 |
| HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND | DOUBLED | 173,798 | 485,545 | +179.4% | $36.7M | 2026-Q1 |
| Capula Management Ltd | DOUBLED | 196,184 | 465,126 | +137.1% | $35.2M | 2026-Q1 |
| CAPITOLIS LIQUID GLOBAL MARKETS LLC | NEW | — | 445,385 | — | $33.7M | 2026-Q1 |
| GABELLI FUNDS LLC | ADD | 285,742 | 382,142 | +33.7% | $28.9M | 2026-Q1 |
| BNP Paribas Asset Management Holding S.A. | TRIM | 640,183 | 368,011 | -42.5% | $27.8M | 2026-Q1 |
| DIMENSIONAL FUND ADVISORS LP | NEAR_EXIT | 2,260,052 | 357,911 | -84.2% | $27.1M | 2026-Q1 |
| NATIXIS | DOUBLED | 54,774 | 306,042 | +458.7% | $23.1M | 2026-Q1 |
| ExodusPoint Capital Management, LP | TRIM | 326,035 | 187,082 | -42.6% | $14.1M | 2026-Q1 |
| Korea Investment CORP | DOUBLED | 64,831 | 136,331 | +110.3% | $10.3M | 2026-Q1 |
| FULLER & THALER ASSET MANAGEMENT, INC. | ADD | 96,867 | 134,965 | +39.3% | $10.2M | 2026-Q1 |
18 unique insiders with 50 transactions. Net insider value: $0.00 ($0.00 bought, $0.00 sold).
Insider Transactions
| Date | Insider | Title | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Apr 7, 2026 | COHN BENJAMIN JORDAN | Principal Accounting Officer | D | 17,964 | — | — |
| Apr 7, 2026 | COHN BENJAMIN JORDAN | Principal Accounting Officer | D | 10,861 | — | — |
| Apr 7, 2026 | COHN BENJAMIN JORDAN | Principal Accounting Officer | AWARD | 5,665 | — | — |
| Apr 7, 2026 | COHN BENJAMIN JORDAN | Principal Accounting Officer | D | 5,665 | — | — |
| Apr 7, 2026 | Dockendorff Charles J | Director | D | 6,626 | — | — |
| Apr 7, 2026 | Dockendorff Charles J | Director | D | 5,396 | — | — |
| Apr 7, 2026 | HANTSON LUDWIG | Director | D | 16,146 | — | — |
| Apr 7, 2026 | HANTSON LUDWIG | Director | D | 2,012 | — | — |
| Apr 7, 2026 | MACMILLAN STEPHEN P | Chairman, President and CEO | D | 190,400 | — | — |
| Apr 7, 2026 | MACMILLAN STEPHEN P | Chairman, President and CEO | D | 1,423,837 | — | — |
| Apr 7, 2026 | MACMILLAN STEPHEN P | Chairman, President and CEO | D | 160,565 | — | — |
| Apr 7, 2026 | MACMILLAN STEPHEN P | Chairman, President and CEO | AWARD | 190,400 | — | — |
| Apr 7, 2026 | Madaus Martin D | Director | D | 5,396 | — | — |
| Apr 7, 2026 | Madaus Martin D | Director | D | 1,016 | — | — |
| Apr 7, 2026 | McMillan Wayde D. | Director | D | 4,932 | — | — |
| Apr 7, 2026 | McMillan Wayde D. | Director | D | 5,171 | — | — |
| Apr 7, 2026 | Mohtashami Nanaz | Director | D | 7,371 | — | — |
| Apr 7, 2026 | Mohtashami Nanaz | Director | D | 2,141 | — | — |
| Apr 7, 2026 | Stamoulis Christiana | Director | D | 50,526 | — | — |
| Apr 7, 2026 | Stamoulis Christiana | Director | D | 6,816 | — | — |
| Apr 7, 2026 | Stewart Stacey D. | Director | D | 8,358 | — | — |
| Apr 7, 2026 | Stewart Stacey D. | Director | D | 768 | — | — |
| Apr 7, 2026 | Wendell Amy McBride | Director | D | 25,784 | — | — |
| Apr 7, 2026 | Wendell Amy McBride | Director | D | 1,500 | — | — |
| Apr 7, 2026 | Liddy Anne M. | General Counsel | D | 28,052 | — | — |
| Apr 7, 2026 | De Walt Diana | SVP, Human Resources | D | 7,603 | — | — |
| Apr 7, 2026 | Horvath Mark W. | President, Breast & Skeletal | D | 23,026 | — | — |
| Apr 7, 2026 | Horvath Mark W. | President, Breast & Skeletal | D | 2,490 | — | — |
| Apr 7, 2026 | Horvath Mark W. | President, Breast & Skeletal | AWARD | 7,762 | — | — |
| Apr 7, 2026 | Horvath Mark W. | President, Breast & Skeletal | D | 7,762 | — | — |
| Apr 7, 2026 | Liddy Anne M. | General Counsel | D | 2,173 | — | — |
| Apr 7, 2026 | Liddy Anne M. | General Counsel | AWARD | 3,452 | — | — |
| Apr 7, 2026 | Liddy Anne M. | General Counsel | D | 3,452 | — | — |
| Apr 7, 2026 | Mitchell Essex D | Chief Operating Officer | D | 77,694 | — | — |
| Apr 7, 2026 | Mitchell Essex D | Chief Operating Officer | D | 2,972 | — | — |
| Apr 7, 2026 | Mitchell Essex D | Chief Operating Officer | AWARD | 46,154 | — | — |
| Apr 7, 2026 | Mitchell Essex D | Chief Operating Officer | D | 46,154 | — | — |
| Apr 7, 2026 | Oberton Karleen Marie | Chief Financial Officer | D | 150,735 | — | — |
| Apr 7, 2026 | Oberton Karleen Marie | Chief Financial Officer | D | 30,774 | — | — |
| Apr 7, 2026 | Oberton Karleen Marie | Chief Financial Officer | AWARD | 42,707 | — | — |
| Apr 7, 2026 | Oberton Karleen Marie | Chief Financial Officer | D | 42,707 | — | — |
| Apr 7, 2026 | Schneiders Jennifer M | President, Diag. Solutions | D | 41,462 | — | — |
| Apr 7, 2026 | Schneiders Jennifer M | President, Diag. Solutions | D | 3,804 | — | — |
| Apr 7, 2026 | Schneiders Jennifer M | President, Diag. Solutions | AWARD | 22,598 | — | — |
| Apr 7, 2026 | Schneiders Jennifer M | President, Diag. Solutions | D | 22,598 | — | — |
| Apr 7, 2026 | Schnittker Brandon | President, GYN Surgical | D | 17,644 | — | — |
| Apr 7, 2026 | Schnittker Brandon | President, GYN Surgical | D | 2,265 | — | — |
| Apr 7, 2026 | Schnittker Brandon | President, GYN Surgical | AWARD | 8,432 | — | — |
| Apr 7, 2026 | Schnittker Brandon | President, GYN Surgical | D | 8,432 | — | — |
| Apr 7, 2026 | Verstreken Jan | Group President, International | D | 134,039 | — | — |
5 SEC filing reports analyzed. Sentiment: 0 bullish, 0 bearish, 1 mixed, 4 neutral. Avg impact: 6.4/10.
NEUTRAL
15-12G
7/10
Hologic, Inc. has filed Form 15-12G to terminate its SEC registration and suspend reporting obligati
Apr 17, 2026
NEUTRAL
EFFECT
3/10
Hologic Inc. has two shelf registration statements (File Nos. 333-73596 and 033-65019) that became e
Apr 13, 2026
NEUTRAL
8-K
9/10
Hologic completed its acquisition by Blackstone and TPG, becoming a private company. The deal closed
Apr 7, 2026
NEUTRAL
8-K
7/10
Hologic CEO Stephen MacMillan announced his retirement effective upon the closing of the company's a
Apr 6, 2026
MIXED
INST-CLUSTER
6/10
Institutional activity in Hologic (HOLX) during 2025-Q4 shows a mixed signal: sovereign wealth fund
Feb 28, 2026
No press releases analyzed yet. Press releases are collected from GlobeNewsWire and analyzed by the LLM pipeline.
Historical analyst distribution (last covering-analyst action Jan 2026): 0% buy across 23 analysts — 0 strong buy, 0 buy, 20 hold, 1 sell, 2 strong sell. No current recommendation available.
Analyst Price Targets
Historical data — last covering-analyst action Jan 2026. No current recommendation available.
$76.67 mean target (Jan 2026)
$76.00 Low
$78.00 High
| Metric | Value |
|---|---|
| Current Price | $76.01 |
| Target Low | $76.00 |
| Target Mean | $76.67 |
| Target Median | $76.00 |
| Target High | $78.00 |
| # Analysts | 9 |
| Recommendation | — (no recent coverage) |
Earnings Estimates & Revisions
| Period | EPS Avg | EPS Low | EPS High | EPS Growth | 30d Rev. | Up/Down | Rev. Avg | Rev. Growth | Analysts |
|---|---|---|---|---|---|---|---|---|---|
| Next FY 2027-09-30 |
$3.78 | $3.05 | $4.39 | 15.4% | +0.0% | 0↑ 5↓ | $4.5B | 5.3% | 7 |
| Current FY 2026-09-30 |
$4.46 | $4.35 | $4.64 | 4.6% | +0.8% | 0↑ 8↓ | $4.2B | 3.3% | 15 |
| Current Q 2026-03-31 |
$1.07 | $1.01 | $1.14 | 3.8% | +1.4% | 0↑ 4↓ | $1.0B | 2.5% | 12 |
| Next Q 2026-06-30 |
$1.12 | $1.09 | $1.18 | 4.0% | +1.3% | 1↑ 3↓ | $1.1B | 2.9% | 10 |
Current Quarter EPS Revision History
| Timepoint | EPS Estimate | Change |
|---|---|---|
| Current | $1.069 | |
| 7d ago | $1.054 | +0.015 |
| 30d ago | $1.054 | +0.015 |
| 60d ago | $1.061 | +0.008 |
| 90d ago | $1.099 | -0.029 |
15 analyst firms have rated this stock: 3 upgrades, 9 downgrades, 2 initiations.
Historical Analyst Actions
| Date | Analyst Firm | Action | Previous Rating | New Rating |
|---|---|---|---|---|
| Jan 12, 2026 | Argus Research | DOWNGRADE | Buy | Hold |
| Jan 5, 2026 | Evercore ISI Group | DOWNGRADE | Outperform | In-Line |
| Nov 11, 2025 | Morgan Stanley | MAINTAIN | Equal-Weight | Equal-Weight |
| Oct 23, 2025 | Mizuho | DOWNGRADE | Outperform | Neutral |
| Oct 22, 2025 | Raymond James | DOWNGRADE | Outperform | Market Perform |
| Oct 22, 2025 | Stephens & Co. | DOWNGRADE | Overweight | Equal-Weight |
| Oct 22, 2025 | JP Morgan | DOWNGRADE | Overweight | Neutral |
| Oct 21, 2025 | Leerink Partners | MAINTAIN | Market Perform | Market Perform |
| Oct 21, 2025 | BTIG | REITERATE | Neutral | Neutral |
| Oct 21, 2025 | Needham | REITERATE | Hold | Hold |
| Oct 7, 2025 | Evercore ISI Group | UPGRADE | In-Line | Outperform |
| Sep 19, 2025 | Argus Research | MAINTAIN | Buy | Buy |
| Sep 18, 2025 | Stephens & Co. | REITERATE | Overweight | Overweight |
| Aug 6, 2025 | RBC Capital | UPGRADE | Sector Perform | Outperform |
| Jul 31, 2025 | Morgan Stanley | MAINTAIN | Equal-Weight | Equal-Weight |
| Jul 31, 2025 | UBS | MAINTAIN | Neutral | Neutral |
| Jul 16, 2025 | Mizuho | MAINTAIN | Outperform | Outperform |
| Jul 9, 2025 | Citigroup | UPGRADE | Neutral | Buy |
| Jul 8, 2025 | Evercore ISI Group | MAINTAIN | In-Line | In-Line |
| May 28, 2025 | Needham | REITERATE | Hold | Hold |
| May 13, 2025 | Stephens & Co. | MAINTAIN | Overweight | Overweight |
| May 5, 2025 | Morgan Stanley | MAINTAIN | Equal-Weight | Equal-Weight |
| May 2, 2025 | RBC Capital | MAINTAIN | Sector Perform | Sector Perform |
| May 2, 2025 | Raymond James | REITERATE | Outperform | Outperform |
| May 2, 2025 | Evercore ISI Group | MAINTAIN | In-Line | In-Line |
| May 2, 2025 | Needham | REITERATE | Hold | Hold |
| Apr 8, 2025 | RBC Capital | MAINTAIN | Sector Perform | Sector Perform |
| Mar 4, 2025 | Citigroup | MAINTAIN | Neutral | Neutral |
| Feb 6, 2025 | Raymond James | REITERATE | Outperform | Outperform |
| Feb 6, 2025 | RBC Capital | MAINTAIN | Sector Perform | Sector Perform |
| Feb 6, 2025 | Evercore ISI Group | MAINTAIN | In-Line | In-Line |
| Feb 6, 2025 | Stephens & Co. | REITERATE | Overweight | Overweight |
| Feb 6, 2025 | Leerink Partners | DOWNGRADE | Outperform | Market Perform |
| Feb 6, 2025 | Needham | REITERATE | Hold | Hold |
| Feb 3, 2025 | Needham | DOWNGRADE | Buy | Hold |
| Jan 13, 2025 | Morgan Stanley | MAINTAIN | Equal-Weight | Equal-Weight |
| Jan 13, 2025 | Needham | REITERATE | Buy | Buy |
| Dec 19, 2024 | Needham | REITERATE | Buy | Buy |
| Dec 13, 2024 | Wolfe Research | INITIATE | — | Peer Perform |
| Dec 10, 2024 | Jefferies | INITIATE | — | Hold |
| Nov 5, 2024 | Raymond James | MAINTAIN | Outperform | Outperform |
| Nov 5, 2024 | Mizuho | MAINTAIN | Outperform | Outperform |
| Nov 5, 2024 | UBS | MAINTAIN | Neutral | Neutral |
| Nov 5, 2024 | RBC Capital | MAINTAIN | Sector Perform | Sector Perform |
| Nov 5, 2024 | JP Morgan | MAINTAIN | Overweight | Overweight |
| Oct 15, 2024 | Needham | REITERATE | Buy | Buy |
| Oct 8, 2024 | Leerink Partners | MAINTAIN | Outperform | Outperform |
| Oct 4, 2024 | Mizuho | MAINTAIN | Outperform | Outperform |
| Oct 1, 2024 | Evercore ISI Group | MAINTAIN | In-Line | In-Line |
| Oct 1, 2024 | Citigroup | DOWNGRADE | Buy | Neutral |
Monthly Consensus History
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Buy % | Distribution |
|---|---|---|---|---|---|---|---|
| Jun 1, 2026 | 0 | 0 | 20 | 1 | 2 | 0% | |
| May 1, 2026 | 0 | 0 | 20 | 1 | 2 | 0% | |
| Apr 1, 2026 | 0 | 0 | 20 | 1 | 2 | 0% | |
| Mar 1, 2026 | 0 | 0 | 20 | 1 | 2 | 0% | |
| Feb 1, 2026 | 0 | 0 | 20 | 1 | 2 | 0% | |
| Jan 1, 2026 | 3 | 4 | 18 | 0 | 0 | 28% |
Strong BuyBuyHoldSellStrong Sell
1 members of Congress traded this stock: 0 buys, 1 sells.
Congressional Trades
| Date | Member | Party | Chamber | Type | Amount | Asset | Disclosed |
|---|---|---|---|---|---|---|---|
| Apr 8, 2026 | Laura Friedman | D | HOUSE | EXCHANGE | $1,001 - $15,000 | Hologic Inc | May 15, 2026 (38d) |
| Apr 8, 2026 | Laura Friedman | D | HOUSE | SELL | $1,001 - $15,000 | Hologic Inc | May 15, 2026 (38d) |
No Reddit sentiment data available yet. Sentiment is analyzed from Reddit investment communities on a rolling basis.
Apr 30, 2026
earnings_calendar
HOLX Q2 2026 Earnings After Market Close — 2026-04-30
Apr 6, 2026
dark_pool
Dark Pool: HOLX — 19.1M shares, 33,807 trades
Week starting 2026-04-06. Total ATS volume: 19,125,714 shares across 33,807 trades.
Apr 2, 2026
short_volume
Short Volume: HOLX — 56.6% short (0.3M / 0.6M)
Short: 319,144 | Exempt: 0 | TRF Vol: 564,124 | Short Ratio: 56.6% | Off-exchange volume (dark pool + OTC)
Mar 30, 2026
dark_pool
Dark Pool: HOLX — 2.0M shares, 29,680 trades
Week starting 2026-03-30. Total ATS volume: 1,964,629 shares across 29,680 trades.
Mar 25, 2026
short_interest
FTD: HOLX — 91,223 shares ($6.9M) failed to deliver
Settlement: 20260325, Price: $75.55, FTD Value: $6,891,897.65, HOLOGIC INC
Mar 23, 2026
dark_pool
Dark Pool: HOLX — 2.6M shares, 41,018 trades
Week starting 2026-03-23. Total ATS volume: 2,566,416 shares across 41,018 trades.
Mar 16, 2026
dark_pool
Dark Pool: HOLX — 5.2M shares, 51,363 trades
Week starting 2026-03-16. Total ATS volume: 5,170,500 shares across 51,363 trades.
Mar 9, 2026
dark_pool
Dark Pool: HOLX — 3.6M shares, 46,485 trades
Week starting 2026-03-09. Total ATS volume: 3,571,690 shares across 46,485 trades.
Mar 5, 2026
short_interest
FTD: HOLX — 14,757 shares ($1.1M) failed to deliver
Settlement: 20260305, Price: $75.67, FTD Value: $1,116,662.19, HOLOGIC INC
Mar 4, 2026
short_interest
FTD: HOLX — 9,306 shares ($0.7M) failed to deliver
Settlement: 20260304, Price: $75.46, FTD Value: $702,230.76, HOLOGIC INC
Mar 2, 2026
dark_pool
Dark Pool: HOLX — 3.3M shares, 44,084 trades
Week starting 2026-03-02. Total ATS volume: 3,341,369 shares across 44,084 trades.
Feb 23, 2026
dark_pool
Dark Pool: HOLX — 1.9M shares, 36,975 trades
Week starting 2026-02-23. Total ATS volume: 1,880,090 shares across 36,975 trades.
Feb 20, 2026
short_interest
FTD: HOLX — 26,994 shares ($2.0M) failed to deliver
Settlement: 20260220, Price: $75.14, FTD Value: $2,028,329.16, HOLOGIC INC
Feb 16, 2026
dark_pool
Dark Pool: HOLX — 1.9M shares, 27,937 trades
Week starting 2026-02-16. Total ATS volume: 1,870,387 shares across 27,937 trades.
Feb 9, 2026
dark_pool
Dark Pool: HOLX — 2.0M shares, 36,174 trades
Week starting 2026-02-09. Total ATS volume: 1,982,424 shares across 36,174 trades.